• FirefoxUpgrade to the new Firefox »
  •  Dow Up 2.43% Nasdaq Up 2.24%

    Corcept Therapeutics Incorporated (CORT)

    -NasdaqCM
    3.20 Dec 18, 4:00PM EST
    Add to Portfolio
    Prev Close:3.20
    Open:3.29
    Bid:N/A
    Ask:3.95 x 800
    1y Target Est:3.25
    Beta:2.51
    Earnings Date:Jan 28 - Feb 2 (Est.)
    Day's Range:3.15 - 3.34
    52wk Range:1.69 - 4.49
    Volume:180,941
    Avg Vol (3m):191,098
    Market Cap:323.81M
    P/E (ttm):N/A
    EPS (ttm):-0.38
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CORT 0.00%323.81M
    AZN91.07B
    GSK104.07B
    NVS228.74B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):14.96
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.33
    Quarterly EPS Est (Dec-14) :-0.06
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):-0.21

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Corcept Therapeutics Incorporated, a pharmaceutical company, is engaged in the discovery, development, and commercialization of drugs for the treatment of metabolic, psychiatric, and oncologic disorders in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback